ADDS Cognitive Screening and ADTS Memory Training Systems Deployed in Multiple Leading Hospitals Nationwide Breaking Through the Early Detection and Treatment Challenges of Alzheimer's Disease
Recently, HSAP Medical Systems Co., Ltd.'s independently developed ADDS Cognitive Impairment Screening System and ADTS Memory Impairment Training System have achieved comprehensive clinical application coverage across multiple provinces and cities nationwide.
These dual systems have not only been successfully deployed at top-tier domestic medical institutions such as Tongji Hospital affiliated with Tongji Medical College of Huazhong University of Science and Technology, but have also been widely adopted by mental health centers including the Fourth Affiliated Hospital of Guangzhou Medical University, Shanghai's Jing'an District, Changning District, and Yangpu District Mental Health Centers, Shenzhen Zhongxu Hospital, Inner Mongolia International Mongolian Medicine Hospital, Qian'an People's Hospital, Guangxi Lipu People's Hospital, Gansu Minxian Traditional Chinese Medicine Hospital, and over a dozen other medical institutions of varying levels and specialties. Together, they form a comprehensive neurohealth service network built on China's original technology.
As an innovative achievement integrating three core technologies-artificial intelligence, brain-computer interfaces, and neuromodulation-this dual-system solution establishes a closed-loop "screening-training" diagnostic and treatment pathway. It precisely aligns with the integrated diagnostic model requirements outlined in the 2025 edition of the Chinese Guidelines for the Diagnosis and Treatment of Alzheimer's Disease and Dementia. This approach provides a replicable, highly efficient new clinical pathway for the "early detection, early diagnosis, and early intervention" of Alzheimer's disease in China, earning widespread recognition within the clinical industry.
Industry pain points are becoming increasingly apparent, and the demand for precision diagnosis and treatment is growing more urgent.
Alzheimer's disease, as a globally prevalent neurodegenerative disorder, has become a major public health and social challenge in China. Authoritative data indicates that approximately 20 million individuals aged 60 and above in China suffer from dementia, with Alzheimer's disease accounting for 60%–70% of these cases. The prevalence of mild cognitive impairment among those aged 60 and above reaches 15.5%, corresponding to over 38.87 million affected individuals. The disease has a long clinical latency period of 15–20 years. In its early stages, it manifests only as mild memory impairment and reduced ability to learn new information, often mistaken for "natural aging." Nearly half of patients are diagnosed only after the disease has progressed to the moderate stage, missing the optimal window for intervention.
Traditional diagnostic and treatment models exhibit significant shortcomings: Cognitive screening heavily relies on subjective physician assessments and complex imaging examinations, which are not only time-consuming and costly but also struggle to detect early pathological signals such as β-amyloid deposits and tau protein abnormalities during mild cognitive impairment. Memory training programs often follow generalized protocols, lacking personalized adaptation and scientific regulation. They fail to precisely adjust for specific types of cognitive deficits, making it difficult to effectively slow functional decline. Addressing the industry pain points of "imprecise screening and untargeted training" urgently requires breakthroughs in technological innovation.
Dual systems synergize to establish a closed-loop precision diagnosis and treatment process
Leveraging extensive technical expertise in medical electronics, HSAP introduces an integrated "Screening-Training" solution that bridges diagnostic gaps through technological synergy, achieving comprehensive coverage from early detection to targeted intervention:
The ADDS Cognitive Impairment Screening System employs non-invasive brain-computer interface technology to collect real-time neural signals via high-precision electrodes. Combined with proprietary AI deep learning algorithms, it quantitatively assesses multidimensional cognitive abilities, including memory, attention, and executive function. The screening takes only 15 minutes to complete with over 90% accuracy and user-friendly operation. It meets the precise diagnostic needs of tertiary hospitals while also being suitable for large-scale community population screening and risk stratification, securing the golden window for intervention and treatment.
The ADTS Memory Impairment Training System aligns with guideline recommendations for cognitive training: "3-5 sessions per week for over 3 months." Employing non-invasive brain-computer interface technology, the system enables users to control rehabilitation games through thought, enhancing approximate entropy and brain complexity to prevent memory decline. Clinical practice demonstrates that patients with mild to moderate cognitive impairment achieve an average MMSE score improvement of 4–6 points after over 3 months of training, with significant enhancements in activities of daily living and cognitive function. This effectively addresses the targeted therapy shortcomings of traditional rehabilitation training.
The combined application of the ADDS cognitive impairment screening system and the ADTS memory impairment training system establishes a closed-loop neuromodulation system encompassing "assessment-stimulation-monitoring-optimization," promoting neuroplasticity restoration through closed-loop management.
Empowering full-scenario implementation to activate a diverse healthcare ecosystem
The nationwide deployment of this dual-system across multiple institutions has fully validated its broad applicability and clinical utility, catering to the personalized needs of diverse healthcare settings:
Leading Tertiary Hospitals: Neurological treatment benchmarks like Tongji Hospital leverage the system to enhance the precision and efficiency of cognitive impairment diagnosis and treatment. It provides objective data support for individualized therapy in complex cases, optimizing the integrated diagnostic process combining biomarkers and clinical symptoms.
Specialized and niche institutions: Mental health centers in Shanghai's Jing'an, Changning, and Yangpu districts utilize the system for community-based early screening and tiered interventions, improving treatment adherence among individuals with subjective cognitive decline. Inner Mongolia International Mongolian Medicine Hospital explores synergistic pathways combining modern technology with traditional medicine, injecting innovative vitality into neurological health safeguards for ethnic regions.
Primary healthcare institutions: Qian'an People's Hospital, Lipu People's Hospital, Minxian Traditional Chinese Medicine Hospital, and others leverage the system to extend specialized expertise to grassroots levels, addressing the lack of precise screening tools in rural areas and advancing early screening and diagnosis of Alzheimer's disease to county-level regions.
Regional specialty hospitals: The Fourth Affiliated Hospital of Guangzhou Medical University (National Comprehensive Stroke Center) utilizes the system for post-stroke cognitive impairment rehabilitation management, enhancing comprehensive neurodiagnostic and therapeutic services. Shenzhen Zhongxu Hospital has optimized the entire service process for elderly patients with cognitive impairment through the system, enhancing care quality.
"The integration of ADDS and ADTS transforms the traditional cognitive diagnosis and treatment model, which relied on experience and lacked targeted approaches. AI algorithms can continuously iterate and optimize, providing reliable technical support for personalized treatment," "A neurology specialist noted that the system's diagnostic capabilities align closely with guideline-recommended precision requirements, significantly boosting clinical efficiency. The head of geriatrics at a Shanghai district mental health center also highlighted the system's user-friendly operation, which lowers the technical barrier for cognitive impairment prevention and treatment, laying the groundwork for large-scale implementation.
Continuously innovating and iterating to advance the implementation of the Healthy China strategy
Currently, HSAP has established long-term clinical collaboration mechanisms with over ten hospitals nationwide. Through data sharing and joint research, the system continuously optimizes its algorithmic models and clinical adaptability, driving deep integration between technology and clinical needs.
Moving forward, the company will further align with national policy directives such as the Healthy China Initiative (2019–2030) and the Implementation Plan for Promoting Dementia Prevention and Control. This includes expanding the dual-system into community health service centers, elderly care facilities, and health management centers to advance the widespread adoption of early Alzheimer's screening. Simultaneously, it will deepen industry-academia-research collaborations with leading scientific institutions to advance breakthroughs in key neurostimulation technologies and iteratively refine personalized training protocols. This will extend the benefits of China's original technological innovations to more regions and patients, injecting robust innovative momentum into the high-quality development of China's neurological health sector and the "Healthy China" initiative.